Literature DB >> 19770196

The RE-LY study: Randomized Evaluation of Long-term anticoagulant therapY: dabigatran vs. warfarin.

A John Camm1.   

Abstract

Entities:  

Year:  2009        PMID： 19770196     DOI： 10.1093/eurheartj/ehp384

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  10 in total

1.  Severe haematuria of lower urinary tract origin with low dose dabigatran use in three Indian elderly patients: unresolved issues in the safety of novel oral anticoagulants.

Authors:  Upinder Kaur; Sankha Shubhra Chakrabarti; Sukdev Manna; Indrajeet Singh Gambhir
Journal:  Ther Adv Drug Saf       Date:  2017-11-23

2.  Patients' perspectives regarding long-term warfarin therapy and the potential transition to new oral anticoagulant therapy.

Authors:  Elizabeth S Gebler-Hughes; Linda Kemp; Malcolm J Bond
Journal:  Ther Adv Drug Saf       Date:  2014-12

3.  Is dabigatran efficacy enough to prevent stroke in atrial fibrillation patient with high CHADS2 score during peri-procedural catheter radiofrequency ablation? A case report with literature review.

Authors:  Xiang-Min Shi; Fu-Kun Chen; Zhuo Liang; Jian Li; Kun Lin; Jian-Ping Guo; Zhao-Liang Shan
Journal:  Int J Clin Exp Med       Date:  2015-04-15

Review 4.  Direct thrombin inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in people with non-valvular atrial fibrillation.

Authors:  Carlos A Salazar; Daniel del Aguila; Erika G Cordova
Journal:  Cochrane Database Syst Rev       Date:  2014-03-27

5.  Assessment of a Pharmacist-Led Direct Oral Anticoagulant Monitoring Clinic.

Authors:  Jenna Haché; Kwadwo Osei Bonsu; Rufaro Chitsike; Hai Nguyen; Stephanie Young
Journal:  Can J Hosp Pharm       Date:  2021-01-01

6.  Triple therapy after PCI - Warfarin treatment quality and bleeding risk.

Authors:  Daniel Wadell; Jens Jensen; Erling Englund; Anders Själander
Journal:  PLoS One       Date:  2018-12-18       Impact factor: 3.240

7.  Dabigatran Monitoring Was Influenced by Thrombin Time Reagent With Different Thrombin Concentrations.

Authors:  Xiaoping Xu; Qian Liang
Journal:  Clin Appl Thromb Hemost       Date:  2019 Jan-Dec       Impact factor: 2.389

Review 8.  Efficacy and Safety of Non-Vitamin K Anticoagulants for Atrial Fibrillation in Relation to Different Renal Function Levels: A Network Meta-Analysis.

Authors:  Hao Jin; Kongbo Zhu; Lina Wang; Yifan Li; Jingjun Meng; Hong Zhi
Journal:  Cardiovasc Ther       Date:  2020-04-22       Impact factor: 3.023

9.  An observational study of international normalized ratio control according to NICE criteria in patients with non-valvular atrial fibrillation: the SAIL Warfarin Out of Range Descriptors Study (SWORDS).

Authors:  Daniel E Harris; Daniel Thayer; Ting Wang; Caroline Brooks; Geoff Murley; Mike Gravenor; Nathan R Hill; Steven Lister; Julian Halcox
Journal:  Eur Heart J Cardiovasc Pharmacother       Date:  2021-01-16

10.  Cardiac arrest due to left circumflex coronary artery embolism as a complication of subtherapeutic oral anticoagulation in a patient with mitral and aortic mechanical valve prostheses.

Authors:  Marcin Protasiewicz; Aleksandra Rojek; Jacek Gajek; Andrzej Mysiak
Journal:  Postepy Kardiol Interwencyjnej       Date:  2013-03-21       Impact factor: 1.426
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.